Phase 1 Coronary Heart Disease Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Premature Coronary Heart DiseaseHeterozygous Familial Hypercholesterolemia
Verve Therapeutics, Inc.85 enrolled22 locationsNCT06164730
Recruiting
Phase 1Phase 2
A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease
Coronary Heart DiseaseCoronary Artery DiseaseAtheroscleroses
Xia Liang30 enrolled1 locationNCT07493603
Completed
Phase 1
A Dose-Escalation Safety Study of Yindan Softgels in Healthy Subjects
ischemic stroke sequelaeunstable angina pectoris of coronary heart disease (CHD)
Axeon Research (Au) Pty Ltd.40 enrolled1 locationACTRN12618000582257
Completed
Phase 1
To determine whether a pharmacokinetic drug-drug interaction occurs between atorvastatin and elinogrel.
chronic coronary heart disease (CHD)
Novartis Pharmaceutical Pty Limited28 enrolled1 locationACTRN12611000315910
Recruiting
Phase 1
Weight Management Program for People with Cardiac Disease and Diabetes
weight management in people with existing coronary heart disease and/or type 2 diabetes mellitus
University of Technology, Sydney168 enrolled1 locationACTRN12609000488202